Frank Yiannas helped lead the FDA’s response to the baby-formula recall and ensuing shortages.
WASHINGTON—The baby-formula industry remains as vulnerable to safety problems and supply disruptions as it did more than a year ago, when a recall led to nationwide shortages, a former Food and Drug Administration official says in testimony submitted for a congressional hearing Tuesday.
“The nation remains one outbreak, tornado, flood, or cyberattack away from finding itself in a similar place to that of February 17, 2022,” Frank Yiannas , the former deputy FDA commissioner for food policy and response, says in testimony prepared for a hearing by the House Oversight Committee’s healthcare panel.
Mr. Yiannas helped lead the agency’s response to the formula recall and ensuing shortages.